КОМПАНИЯ

ORANGE, Calif. July 25, 2024 – Providence St. Joseph Hospital announced it has successfully performed the world’s first robotic spinal surgery using a new open spine platform by eCential Robotics to implant a Spineart medical device.

eCential Robotics, a surgical robotics company which developed the open surgical platform and Spineart, a leader in spine surgery innovation, are collaborators in a new age of open technology sharing that allows cross-functional use of implantation devices and robotic surgical platforms.

“In our relentless pursuit of innovation and excellence in patient care, we were eager to utilize the solutions provided by Spineart and eCential,” said Erick Westbroek*, M.D., Providence St. Joseph spinal surgeon. “The integration of Spineart’s advanced implant system with eCential’s open robotic platform will enable us to perform minimally invasive surgeries with high predictability, reproducibility and outcomes.”

Providence St. Joseph Hospital has become the first clinical institution in the world to be equipped with the state-of-the-art robot, and the recent surgeries are the first in the United States to be used successfully in conjunction with Spineart implants.

“St. Joseph Hospital has built a strong reputation for world-class surgical care, and our patients often travel from far and wide to seek treatment and care from our stellar spine and orthopedic surgeons, who are armed with cutting-edge technology,” said Brian Helleland, chief executive of Providence St. Joseph Hospital and the Orange County/High Desert area. “These advances provide yet another sophisticated platform for our surgeons to do what they do best.”

“We are thrilled to announce the installation of this state-of-the-art robot at St. Joseph Hospital,” said Jerome Trividic, CEO of Spineart. “We believe this advancement will greatly benefit our customers, hospitals, surgeons, and patients by enhancing surgical precision and improving patient outcomes.”

St. Joseph’s surgical cases for eCential Robotics are a first-in-human use of its unified robotic technology, as well as the start of eCential operations in the US. It also marks the introduction of cutting-edge solutions that address the evolving needs of surgeons and patients worldwide.

“We are pleased to see the adoption of our technology in the US,” Clément Vidal, CEO of eCential Robotics. “There is strong interest and momentum for our open solution because it allows surgeons to select the optimal implant system for each patient while providing financial advantages to hospitals. Our platform is described as the smartphone of surgical robots.”

* Dr. Erick Westbroek is a paid consultant of Spineart. His statements represent his own opinions based on personal experience and are not necessarily those of Spineart.

Geneva, Switzerland – June 28, 2024 – Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer.

In his new role, Laurent will be based in the United States and will lead Spineart’s strategic initiatives in enabling technologies, focusing on digital surgical planning, navigation and robotics.

Laurent joins Spineart with over 25 years of experience in biomechanics, surgical navigation, innovation and intellectual property. Prior to joining Spineart, he served as Managing Director at General Electric, playing a pivotal role in advancing GE Healthcare’s 3D imaging and navigation technologies.

“We are delighted to welcome Laurent Nodé-Langlois to Spineart as our Chief Technology Officer,” said Jerome Trividic, CEO of Spineart. “His extensive expertise and proven track record in leading transformative advancements in enabling technologies will be instrumental as we continue to innovate and expand our capabilities in spine surgery.”

As Chief Technology Officer, Laurent will oversee Spineart’s enabling technologies strategy, including managing our investments and collaborations with healthtech and deeptech startups, as well as enhancing Spineart’s intellectual property portfolio. This strategic new Executive role underlines Spineart’s commitment to deliver cutting-edge solutions for spine surgeons worldwide.

“I am excited to join Spineart and lead the Enabling Technologies business unit at such a pivotal time in the industry,” said Laurent Nodé-Langlois. “I look forward to leveraging my experience and collaborating with the talented team at Spineart and their partners to advance our technological capabilities and drive innovation that improves patient outcomes.”

Spineart proudly announces the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET® AC-Ti secured anterior cervical cage.

The SCARLET® AC-Ti builds on a decade of experience with the SCARLET® system. The SCARLET® AC-Ti addition introduces new features such as the MIMETIX® morphometric profile, developed with digital models of the vertebrae to optimize the contact surface between implant and endplates. The system allows for fixation with screws and anchors.

The SCARLET® AC-Ti cervical cage utilizes Spineart’s proprietary Ti-LIFE technology¹. Ti-LIFE technology, a proprietary additive manufacturing process, has a porous structure that closely mimics the trabecular bone structure.

“This approval underscores our commitment to innovation, continuously evolving our most successful products, such as the SCARLET® system” said Alessia Erlingher, Chief Commercial Officer at Spineart.